Full Text
Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis

Abstract

Authors

A Morell E Ramírez I Llorente R García-Vicuña AJ Blasco

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×